98%
921
2 minutes
20
Background: Physiological changes in the coronary circulation associated with percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) remain largely unknown. This systematic review and meta-analysis aimed to investigate physiological changes in the CTO and donor vessel before and immediately after PCI, as well as at follow-up.
Methods: A comprehensive search of PubMed/MEDLINE and Embase identified relevant studies. The primary end point was the mean difference (MD) between fractional flow reserve myocardium (FFR) of the primary donor vessel before and after CTO revascularization. Secondary outcomes included the difference in FFR, FFR collateral (FFR), FFR coronary (FFR), absolute coronary blood flow, coronary flow velocity reserve, and microvascular resistance before and after CTO revascularization and/or at the follow-up.
Results: A total of 17 studies were included. The myocardial blood flow in the donor vessel increased after CTO revascularization (FFR: MD, 0.04; 95% CI, 0.02-0.06; < .01), as well as in the CTO vessel (MD, 0.45; 95% CI, 0.27-0.64; < .01). At follow-up, CTO PCI was associated with a significant shift in collateral (FFR: MD, -0.16; 95% CI, -0.18 to -0.15; < .01) and epicardial blood supply (FFR: MD, 0.09; 95% CI, -0.01 to 0.20; = .06). Time-dependent changes in the microcirculatory domain of the CTO vessel were observed in terms of improved arteriolar dynamicity and decreased microvascular resistance.
Conclusion: Available evidence suggests that CTO revascularization leads to an immediate and long-term improvement in blood supply to downstream myocardium, mediated in part by a favorable time-dependent shift in epicardial vessel, collateral, and microcirculatory function.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11887561 | PMC |
http://dx.doi.org/10.1016/j.jscai.2024.102452 | DOI Listing |
Vasc Health Risk Manag
September 2025
Department of Cardiology and Vascular Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia.
Introduction: Ischemic cardiomyopathy is the leading cause of heart failure and associated with increased morbidity and mortality. The role of percutaneous coronary intervention (PCI) in term of increasing survival and cardiovascular outcomes in ischemic cardiomyopathy remains unclear.
Purpose: To evaluate whether revascularization is associated with 30-day survival in ischemic cardiomyopathy in Dr.
Eur Heart J Case Rep
September 2025
Cardiovascular Division, National Hospital Organization Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan.
Background: Guide extension catheters are specially designed for percutaneous coronary intervention (PCI) to enhance backup support of the guide catheter by providing coaxial alignment, thereby allowing deep intubation of the catheter. We have developed an innovative auxiliary support technique utilizing a dual guide extension catheter system, designed to enhance safety and facilitate deep coronary artery access.
Case Summary: A male in his sixties who presented with chest pain was diagnosed with non-ST elevation myocardial infarction.
Catheter Cardiovasc Interv
September 2025
IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.
Background: Given the divergence in recommendations regarding the relevance of inducible ischemia regarding the indication to revascularize chronic total occlusions (CTOs) among European and North American guidelines, we aim at investigating the prevalence and the prognostic impact of significant inducible ischemia in an unselected cohort of asymptomatic CTO patients, integrating collateralization status and viability assessment with stress cardiac magnetic resonance (CMR).
Methods: From a cohort of 749 patients referred to our center with a diagnosis of CTO, we retrospectively analyzed 111 asymptomatic individuals who underwent an adenosine stress CMR. The amount of inducible ischemia subtended by the CTO was calculated, as well as the presence of viable myocardium and the collateralization status.
Acta Diabetol
September 2025
Department of Systems of Medicine, University of Tor Vergata, Rome, 00133, Italy.
Aim: The study aimed to evaluate the rate and causes of major amputation in patients with diabetic foot syndrome.
Methods: The current study is a retrospective observational study including consecutive patients referred to a tertiary-level diabetic foot service from January 2020 to November 2023 due to a new diabetic foot problem requiring hospital admission. All patients had been managed by a multi-disciplinary diabetic foot team (MDFT) through a pre-set limb salvage protocol including the management of peripheral arterial disease, infection, foot offloading, and comorbidities.
Cardiovasc Revasc Med
August 2025
Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, 6565 Fannin St, Houston, TX 77030, United States of America. Electronic address:
Background: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains technically challenging, with ongoing debate about procedural success predictors and long-term outcomes. We report real-world data from the Houston Methodist CTO PCI Registry to characterize procedural success, safety, and mid- to long-term outcomes.
Methods: We retrospectively analyzed 507 patients undergoing CTO PCI between 2018 and 2023.